On August 6, 2019, the President signed into law H.R. 3253, the "Sustaining Excellence in Medicaid Act of 2019." This law extends certain Medicaid demonstration programs and other Medicaid provisions. It also adjusts the methodology for calculating the price paid for drugs and biologics by State Medicaid programs.